Status:
COMPLETED
GnRH Antagonist to Prepare Recipients for Embryo Transfer
Lead Sponsor:
Institute for Human Reproduction (IHR)
Conditions:
Infertility
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
26% of all ART cycles performed in the USA in 2003 (CDC data) are frozen embryo transfers (FET) and transfer of embryos resulting from egg donation (ED) to recipients. The typical protocol used to pre...
Eligibility Criteria
Inclusion
- History of infertility before cryopreserving the embryos or inability to conceive from her own oocytes (based on age and/or a serum FSH \> 15 IU/L).
- Any patient desiring to become pregnant as a result of transferring frozen-thawed embryos generated using her own or donor oocytes.
- Subject is in good health as determined by the Investigator on the basis of medical history, physical examination and laboratory screening tests.
- A negative pregnancy test prior to starting treatment with estrogens.
Exclusion
- Women with a history of liver and/or kidney disease
- Hypertension: systolic pressure over 180 mm Hg or diastolic pressure over 105 at any study visit, measured twice 6 hours apart despite active treatment for hypertension.
- Liver function tests of two times than the upper limit of normal
- Women with active sever endometriosis.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00460642
Start Date
January 1 2007
End Date
December 1 2009
Last Update
May 26 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Human Reproduction (IHR)
Chicago, Illinois, United States, 60657
2
Institute for Human Reproduction (IHR)
Oakbrook Terrace, Illinois, United States, 60181